Monitoring heart and breathing during pulmonary clot removal
Part of Heart & circulation, Lungs & breathing clinical trials.
This study looks at how your heart and breathing hold up during a minimally invasive procedure to remove a blood clot from your lungs. It aims to understand how to keep patients stable during the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a blood clot in your lungs (pulmonary embolism) that is considered high-risk or intermediate-high-risk (severe and needing urgent care).
- You must be having a minimally invasive procedure to remove the clot (percutaneous pulmonary thrombectomy) as part of your standard care.
- You must not be in a state of very low blood pressure that does not improve with treatment when you arrive for the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests the Vibrato Aspiration System, a device that suctions blood clots from the lungs in people with a recent pulmonary embolism (PE). It aims to see if the procedure is safe and works well for removing clots.
This study compares two ways to treat a large blood clot in the lungs that is causing life-threatening symptoms. One method uses a device to remove the clot, the other uses medicine to dissolve it.
This study tests a procedure to remove blood clots from the lungs in people with moderate or severe pulmonary embolism. It may help reduce strain on the heart and improve recovery.
This trial tests a procedure to remove blood clots from the lungs using a tube (catheter) to open blocked vessels. It may help people with a sudden pulmonary embolism who are stable enough to undergo the procedure.
This trial tests a device called the FlowTriever to remove blood clots from the lungs in people with a pulmonary embolism that is not too severe. The goal is to see if this treatment can help improve heart function and symptoms without major surgery.
This study tests a new device (AlphaVac) that removes blood clots from the lungs using a thin tube inserted through a vein. It may be an option for people with acute pulmonary embolism who have signs of heart strain or low blood pressure.
Hear when a new Pulmonary Embolism Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.